Nicolas Villain, M.D., Ph.D.

Sorbonne University - APHP - Pitié-Salpêtrière Hospital

Contact Information

Nicolas Villain, M.D., Ph.D.
Paris, France

Professional Information

Dr.
Sorbonne University - APHP - Pitié-Salpêtrière Hospital

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:

NV received research support from Fondation Bettencourt-Schueller, Fondation Servier, Union Nationale pour les Intérêts de la Médecine (UNIM) and Fondation pour la Recherche sur l’Alzheimer; travel grant from the Movement Disorders Society, Merz-Pharma and GE Healthcare SAS; is an unpaid sub-investigator in NCT04241068 (aducanumab, Biogen), NCT04437511 (donanemab, Eli-Lilly), NCT04592341 (gantenerumab, Roche), NCT03887455 (lecanemab, Eisai), NCT03352557 (gosuranemab, Biogen), NCT03828747 and NCT03289143 (semorinemab, Roche), NCT04619420 (JNJ-63733657, Janssen – Johnson & Johnson), NCT04374136 (AL001, Alector), NCT04592874 (AL002, Alector); and has given unpaid lectures in symposia organized by Eisai.